P

Pierrel SpA
MIL:PRL

Watchlist Manager
Pierrel SpA
MIL:PRL
Watchlist
Price: 1.745 EUR Market Closed
Market Cap: 95.9m EUR
Have any thoughts about
Pierrel SpA?
Write Note

Pierrel SpA
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pierrel SpA
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
Pierrel SpA
MIL:PRL
Cash from Operating Activities
€7.9m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Cash from Operating Activities
-€13.4m
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Cash from Operating Activities
€530.4m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
11%
Friulchem SpA
MIL:FCM
Cash from Operating Activities
€3.7m
CAGR 3-Years
97%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Shedir Pharma Srl Unipersonale
MIL:SHE
Cash from Operating Activities
€599k
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pierrel SpA
Glance View

Market Cap
95.9m EUR
Industry
Pharmaceuticals

Pierrel SpA engages in the development, manufacturing, and marketing of medical therapies for the pharmaceutical, bio-pharmaceutical, and life science industries. The company is headquartered in Capua, Caserta. The company went IPO on 2006-05-23. The firm specializes in the pharmaceutical research, development and the manufacture of medicines. The company operates through three segments. The Contract Manufacturing segment covers research and development of various types of drugs, such as Tube vials, bottles, ampoules, drops, sprays, tablets and gels. The company manufactures the drugs in the production facility in Capua, which consists of warehouses, chemical and microbiological laboratories, offices and utilities buildings. The Pharma segment is active in the development, registration and licensing of new drugs and medical devices. The Tech-driven Contract Research & Development Organization segment provides research of existing drugs for the treatment of rare diseases, among others.

PRL Intrinsic Value
1.849 EUR
Undervaluation 6%
Intrinsic Value
Price
P

See Also

What is Pierrel SpA's Cash from Operating Activities?
Cash from Operating Activities
7.9m EUR

Based on the financial report for Jun 30, 2023, Pierrel SpA's Cash from Operating Activities amounts to 7.9m EUR.

What is Pierrel SpA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
24%

Over the last year, the Cash from Operating Activities growth was 23%. The average annual Cash from Operating Activities growth rates for Pierrel SpA have been 24% over the past three years .

Back to Top